Video

Camupepimut shows early disease free survival signal in resected KRAS mutated pancreatic cancer

TALENT: Neoadjuvant T-DXd with or without anastrozole, or in sequence with chemo for HER2-low, HR+ early-stage breast cancer

AI tool identifies patients most likely to benefit from extended endocrine therapy in hormone receptor-positive breast cancer

Extended letrozole improves disease-free survival in hormone receptor-positive breast cancer: 15-year results

Perioperative pembrolizumab fails to significantly improve event-free survival in muscle-invasive bladder cancer

Sacituzumab govitecan combination shows promising activity in first line metastatic urothelial cancer

UEG 2026: Improving early detection of colorectal cancer

Tarlatamab's role in SCLC

WCLC 2026: Lung cancer research highlights

Safeguarding the right to work for people with advanced breast cancer (ABC) and their caregivers: A global snapshot of legislati

Equitable precision oncology in Africa

Harnessing AI and data to predict, personalise and transform cancer care